Literature DB >> 7116885

Hemodialysis in septic patients: improvements in tolerance of fluid removal with concentrated albumin as the priming fluid.

F Jardin, J F Prost, Y Ozier, A Margairaz.   

Abstract

Hemodynamic function and volume of ultrafiltration (UF) during hemodialysis were studied in 8 patients with anuric acute renal failure (ARF) and severe sepsis. Patients were alternatively dialyzed with a saline priming (every 2 days) and with a 17.5% albumin priming. Hypovolemia, as indirectly reflected by reduced left ventricular filling pressure, decreased cardiac output (CO), and decline in mean systemic arterial pressure (MAP), was observed during the hemodialysis procedure using saline as the first prime. Hemodialysis was tolerated better after concentrated albumin priming; left ventricular filling pressure increased during the 1st h of dialysis, whereas CO and MAP remained close to that of control values. Furthermore, UF could be increased progressively without major hemodynamic consequences in the patients who received a concentrated albumin priming; moreover, larger volumes of fluid were removed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116885

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 2.  Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review.

Authors:  Adrianna Douvris; Khalid Zeid; Swapnil Hiremath; Sean M Bagshaw; Ron Wald; William Beaubien-Souligny; Jennifer Kong; Claudio Ronco; Edward G Clark
Journal:  Intensive Care Med       Date:  2019-08-12       Impact factor: 17.440

3.  A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients.

Authors:  Etienne Macedo; Bethany Karl; Euyhyun Lee; Ravindra L Mehta
Journal:  Crit Care       Date:  2021-01-06       Impact factor: 9.097

4.  Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study).

Authors:  Edward G Clark; Lauralyn McIntyre; Irene Watpool; Jennifer W Y Kong; Tim Ramsay; Elham Sabri; Mark Canney; Gregory L Hundemer; Pierre-Antoine Brown; Manish M Sood; Swapnil Hiremath
Journal:  Ann Intensive Care       Date:  2021-12-13       Impact factor: 6.925

5.  The Use of I.V. Albumin During Kidney Replacement Therapy: A Survey of Nephrologists and Intensivists.

Authors:  Ryan J Chan; William Beaubien-Souligny; Samuel A Silver; Sean M Bagshaw; Ron Wald; Pierre-Antoine Brown; Swapnil Hiremath; Jennifer W Y Kong; Edward G Clark
Journal:  Kidney Int Rep       Date:  2021-12-08

Review 6.  Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy.

Authors:  Nicole Hryciw; Michael Joannidis; Swapnil Hiremath; Jeannie Callum; Edward G Clark
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-28       Impact factor: 8.237

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.